Drug Approvals

Breaking News

MSD Inaugurates New Technology Centre in Hyderabad to Drive Global Healthcare Innovation and Digital Capabilities

MSD (Merck & Co., Inc.), one of the world's leading global life sciences companies, has officially inaugurated its new state-of-the-art Technology Centre in Hyderabad, marking a significant milestone in...
Breaking News

Bharat Technology Announces BT-PHARMACON 2K26 with Focus on Indigenous Pharma Innovation

Bharat Technology is set to organise BT-PHARMACON 2K26, an ANRF-sponsored national conference on September 26–27, 2026, at the Eastern Zonal...
Breaking News

ChrysCapital to Acquire 20-25% Stake in Linux Laboratories for ₹600 Crore

Private equity firm ChrysCapital is all set to acquire a strategic stake in Linux Laboratories, a Chennai-based specialty pharmaceutical company focused on central nervous...
Breaking News

India Spotlights Massive Health Workforce Expansion at WHO RC79; SEARO Adopts Historic Dili Declaration

The Ministerial Roundtable addressing on"Human Resources for Health: Equity in Specialized Care" at the 79th Session of the WHO Regional...
Breaking News

Johnson & Johnson Presents New Clinical Data Across Bipolar Mania, Depression and Schizophrenia

Johnson & Johnson announced the presentation of comprehensive new clinical and real-world data across its industry-leading neuropsychiatry portfolio...

Novo Nordisk’s Etavopivat Cracks Phase 3 Goals: A Potential New Standard of Care for Sickle Cell Disease

Breaking News Dose Daily News Bureau Dose Daily News Bureau -
Novo Nordisk’s Etavopivat hits the mark in Pivotal Sickle Cell Study. Etavopivat, an oral, once-daily pyruvate kinase-R (PKR) activator displayed supercilious results showing 27%...
1...789Page 9 of 9